logo
When Europe Ate Mummies: How Colonial Cannibalism Lasted Centuries

When Europe Ate Mummies: How Colonial Cannibalism Lasted Centuries

CairoScene21-05-2025
In the grainy photograph, the man sits cross-legged beside two stiff, linen-wrapped corpses. The vendor does not smile. His posture suggests this is ordinary business. In a sense, it was.
That year, in 1865, Western travellers to Egypt could buy a mummified body. Once destined for the afterlife, these ancient dead had become commercial goods, shipped by the crate-load to Europe where they were crushed into pigment, powdered for medicine, unwrapped at parties, or, most disturbingly, consumed.
The practice, colloquially referred to as 'mummy medicine', was more than a passing fad. For centuries, Europeans ingested the remnants of ancient Egyptians with the belief that doing so might heal them. The logic, though warped by distance and desire, was not incidental. It was built on a collision of scientific misunderstanding, colonial hunger, and philosophical confusion about what the dead owe the living.
The belief in mumia's healing power was deeply rooted in prevailing medical theories of the time. One such theory was the doctrine of signatures, which held that natural substances resembled the ailments they were meant to cure. Mummified flesh, preserved for centuries, seemed an obvious candidate for treating decay, wounds, and internal deterioration.
The origins of this strange commerce trace back to a linguistic and pharmacological confusion. In the Arabic language, the word 'mumia' referred to bitumen, a sticky, tar-like substance used by ancient Egyptians in the embalming process. Bitumen itself was thought to possess curative properties, especially for internal bleeding or bruising. By the 12th century, European apothecaries had begun importing it under the same name.
But over time, the material truth behind mumia shifted. As medieval physicians and pharmacists grew more eager for the miraculous powers of 'mummy,' they began harvesting it not from mineral deposits, but from the mummified bodies themselves. Whether by misunderstanding or willful redefinition, the corpse had replaced the compound itself.
By the 16th century, mummy powder, scraped from desiccated flesh and ground into a fine brown dust, was a fixture in European pharmacies. 'Take the bones of an unspoiled mummy,' advised French physician Guy de la Fontaine, 'reduce them to powder and mix them with a bit of wine.' This was mainstream medicine for them.
A 1672 edition of the London Pharmacopoeia recommended mumia vera aegyptiaca, 'true Egyptian mummy', as a treatment for epilepsy, bruising, and internal hemorrhage. The French king Francis I is said to have carried mummy powder in a pouch around his neck. The British aristocracy swallowed it by the spoonful. Sanctified cannibalism was justified scientifically.
To understand how such a practice could be so widely accepted, one must examine the medical logic of the time. Renaissance and early modern medicine was dominated by the humoral theory, in which health depended on the balance of four bodily fluids: blood, phlegm, black bile, and yellow bile. Illness indicated imbalance. Remedies were needed to counteract it.
Mummified flesh, being dry and dark, was seen as ideal for absorbing excess humors. Moreover, the fact that these remains had withstood centuries in desert tombs seemed to signify resilience.
'There was also the allure of the exotic. Egypt, ancient, mysterious, and distant, offered an imaginative cure for European anxieties about death and decay,' Monica Hanna - Egyptian Egyptologist, scholar and Dean at the Arab Academy for Science, Technology & Maritime Transport - tells CairoScene. 'To ingest a mummy was, in effect, to ingest the magic of immortality.'
But this logic carried a darker implication: to consume another human, stripped of name and identity, was acceptable so long as that human came from elsewhere, both geographically and historically. 'What mattered was not the life that had been lived, but the myth that could now be bottled and sold,' Hanna reflects.
The dead served not only the sick, but the vain and the curious. By the 18th century, mummies had become fashionable in European drawing rooms.
Mummy unwrapping parties, popular among Victorian elites, turned human remains into parlour spectacle. Attendees, often wealthy patrons or amateur scholars, would gather to watch an 'orientalist' expert, usually a male collector or physician, slowly peel away the layers of an ancient body. Gasps would follow the unveiling of teeth, nails, amulets. Sometimes a long-preserved hand would be passed around the room.
These events were framed as scientific, even reverent. But their true function was voyeuristic. To unwrap a mummy was to metaphorically dominate the past, to possess not just the body, but the narrative of history.
The echoes of these events are still seen today. 'The mummified body of Shepenese, an ancient Egyptian priestess, lies half-naked in a glass coffin in Switzerland's Abbey Library of St. Gallen — her chest unwrapped. Looted from her tomb in the early 19th century, Shepenese has been exhibited for decades as a tourist attraction. Now, over 200 Egyptian scholars, archaeologists, and civil society figures — joined by Swiss academics and cultural leaders — are demanding her repatriation.' Hanna tells Cairoscene.
Meanwhile, artists were finding another use for the ancient dead. A pigment known as 'mummy brown' was made by boiling ground mummy powder with white pitch and myrrh, resulting in a rich, smoky hue ideal for glazing. The Pre-Raphaelite Brotherhood and other Romantic painters prized it for its depth.
The irony was cruel: in being dismembered and repurposed, the mummies were being 'preserved' again, this time not in linen, but in oil on canvas.
By the mid-19th century, demand had grown so great that supply faltered. Egyptian tombs, already ransacked, were running dry. Enterprising merchants responded with counterfeit mummies, sometimes made from the bodies of contemporary Egyptians, beggars, or criminals, treated with tar and buried briefly in sand to mimic ancient desiccation.
The product is mystique.
Though much of this trade occurred with the complicity of European and Egyptian middlemen alike, it was built on a profound erasure. The people whose bodies were sold, pharaohs and farmers, mothers and children, were never named. Their wishes, if recorded, were discarded. Their tombs, often sealed with prayers for peace, were breached in the name of curiosity and commerce.
European museums and collectors often justified the trade as a civilizing mission: to rescue antiquity from ignorance. Yet as National Geographic notes, this collecting was often indistinguishable from plunder. During Napoleon's Egyptian campaign in 1798, thousands of artifacts were removed from temples and tombs. By the late 1800s, mummy exports from Egypt had become so routine that customs authorities listed them as bulk goods, alongside cotton and dates.
In one reported case, hundreds of mummies were ground up for fertilizer.
'Medical cannibalism, though framed as a rational practice, rested on a deeply irrational foundation: that the dead could be consumed without consequence if they were far enough removed from one's own sense of self. Ingesting a corpse was unthinkable—unless that corpse was foreign, ancient, and exoticised,' Hanna tells CairoScene.
In this, mummy consumption reveals something enduring about the Western philosophical relation to the 'Other'. As philosopher Michel de Montaigne wrote in 1580, condemning European cannibalism of the dead, 'We call barbarous what is not in our customs.' Yet the real barbarity, he implied, lies in the forgetting of the dead's humanity. Scientific historian Louise Noble, writing in the journal Early Modern Literary Studies, describes the practice as 'corporeal colonialism', the literal digestion of the colonial subject. It was not just a metaphor. The British, the French, the Germans, each in their way, absorbed Egypt into their bodies.
'The practice of selling mummies as street commodities, often to tourists, is perhaps the most striking example of cultural commodification,' Hanna asserts. It reflected the pervasive belief that the Egyptian past, with its mysticism and grandeur, could be distilled into an object for consumption. These mummies were displayed as curiosities in European drawing rooms, or worse, sold to apothecaries for use in potions, powders, and medicines. This commodification of human remains, once part of sacred rites, became a direct symbol of the way colonial powers extracted value from native cultures, often disregarding their intrinsic cultural significance in favor of economic gain.
Even as medical cannibalism waned by the late 1800s, its legacy lingered. Anthropologist Beth Conklin, writing in Current Anthropology, has shown how the logic of medicinal corpse consumption often reemerged in other forms of epistemic violence: in the dissection of colonised bodies, the display of human remains in museums, and the extraction of DNA from the dead without consent.
Many of the mummies exported during this time still reside in European institutions. The British Museum alone holds over 120 mummies. In recent years, calls for repatriation have grown louder. In 2022, Egypt formally requested the return of the Rosetta Stone. Other requests have followed for human remains.
Yet few have been granted. Museums often cite preservation, access, and educational value. The irony is painful: that those once consumed for health are now exhibited for knowledge, still denied rest.
"What can we, as Egyptians, do? Accountability for the centuries-long trade in Egypt's dead must go beyond mere repatriation,' Hanna asserts. 'It requires a multifaceted response—one that includes formal apologies from the institutions and nations involved, acknowledging the harm done and the deep disrespect shown to Egyptian culture.'
It is tempting to dismiss this story as a bizarre footnote in the annals of medical history, a quirk of the pre-modern mind. But its contours echo into the present. It reminds us how easily knowledge and power can overwrite reverence. How the desire to understand can slip into the impulse to possess.
The vendor sits beside his cargo, silent, indifferent. We do not know his name. We do not know the names of those beside him.
But we do know this: they were not ingredients. They were people, who lived, and died, and were embalmed with care in the hope of an afterlife. What they received instead was a second death, one not of biology, but of narrative.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Building prosthetic expertise - Economy - Al-Ahram Weekly
Building prosthetic expertise - Economy - Al-Ahram Weekly

Al-Ahram Weekly

time2 days ago

  • Al-Ahram Weekly

Building prosthetic expertise - Economy - Al-Ahram Weekly

Ahmed, in his 40s, is a garage attendant working in a middle-class neighbourhood of Cairo. He relies on crutches after the amputation of one leg. Just two streets away, a 10-year-old boy is playing football. He, too, lives with a disability, as his left hand has been amputated. Neither Ahmed nor the boy has considered using prosthetic limbs. Both belong to vulnerable segments of society and remain unaware of how to access such support through civil society organisations. According to the Central Agency for Public Mobilisation and Statistics, people with disabilities made up approximately 11 per cent of Egypt's population in 2017, with motor disabilities accounting for about 6.8 per cent. To help out this segment of the population, the government is taking steps to localise the production of prosthetic limbs and orthotic devices. The Ministry of Social Solidarity and other relevant authorities are taking the initiative in line with the political leadership's directives to advance this sector. Margaret Saroufim, deputy minister of social solidarity, told Al-Ahram Weekly that 'Egypt is currently developing a system for prosthetic limbs and orthotics, because up till now we have been heavily relying on imported components, especially for limbs with advanced technical specifications, due to the absence of a specialised local industry.' She added that some civil society organisations, including NGOs overseen by the ministry, provide limited services such as basic assembly, maintenance, and adjustments of prosthetic limbs. A national project has now been launched to establish centres for the localisation of prosthetic limb manufacturing in several governorates, Saroufim said, adding that the next step will be establishing an integrated national service system. 'The project will serve as a nucleus for delivering comprehensive services including assessment, fitting, and post-fitting support, while also focusing on technical training in partnership with international experts. This is an important step towards achieving self-sufficiency and providing services in line with international standards and sustainable quality,' she said. Haitham Al-Tabaai, executive director of the Abwab Al-Khair Foundation, a NGO, has been providing prosthetic limbs and devices to those in need for the past 12 years. 'The cost of prosthetic limbs has risen dramatically. When I first began working in the sector, the average price was LE9,000. Just two weeks ago, it was LE55,000,' he said. The price of prosthetic limbs is at the mercy of the dollar exchange rate, he said. One man whose son lost a leg in a train accident had kept saving up to buy a prosthetic limb for his son, but each time he had enough money, the price had risen again, he added. 'Eventually, he had no choice but to seek help from a civil society organisation. It was a heavy burden for him to ask for assistance.' Rising prices have meant that Egypt has abandoned the European market and sought imports from other markets such as Russia, South Africa, and China, which are of lower quality but are much more reasonably priced, Al-Tabaai added. Localising the manufacture of prosthetic limbs and orthotics in Egypt will be a positive step if high-quality products can be provided at a reasonable cost, he added, noting that more NGOs would then be able to offer support in this domain. Saroufim said that one of the key challenges of localising this industry os the absence of the specialised industrial infrastructure capable of producing prosthetic components in accordance with international standards. There is a lack of technological and technical capabilities in this field as well as a shortage of qualified workers, she said, adding that the lack of an integrated system that encompasses training, operations, distribution, and quality control contributes to the problem. Up to now, Egypt has completely depended on imported raw materials and essential components in this field. To address these challenges, Egypt has formed a technical committee made up of representatives from over 30 ministries, authorities, and relevant institutions tasked with studying and overcoming problems hindering the localisation of prosthetic limbs manufacturing on the national level, Saroufim said. The Ministry of Social Solidarity has been tasked with establishing 42 prosthetic limb assembly and fitting centres, to be implemented in six phases. The first phase, already underway, includes the launch of six centres in the Sharqia, Beheira, Ismailia, Assiut, Luxor, and Aswan governorates, she said. 'A leading German company, Ottobock, has been contracted to supply the equipment needed in the centres, provide technical support, and train Egyptian staff to operate the systems,' she added. Establishing a specialised centre for the production and assembly of prosthetic limbs requires a range of technical, structural, and administrative prerequisites, including appropriate infrastructure, modifications to internal engineering systems, and the division of workspaces to align with the various technical stages involved in prosthetic manufacturing, she explained. 'The centres must also be situated near Ministry of Health hospitals to ensure the availability of integrated medical services. Equally important is the design of physically accessible facilities to ensure ease of use for persons with disabilities.' 'Factories producing prosthetic limbs and devices are already active, but they lack new technologies, product quality, and skilled human resources,' Saroufim noted. She referred to the wide variation in the cost of prosthetic limbs, which depends on the type, level of complexity, whether fixed or mobile, and factors such as age appropriateness and the user's daily activity requirements. 'Imported prosthetic limbs are among the most expensive due to their reliance on precision components and specialised technologies,' she added. In distributing prosthetic limb manufactured by national centres, the most vulnerable groups will also be prioritised, Saroufim stated. The disbursement mechanism is structured into three categories: full state coverage for families classified under priority care; partial financial contribution based on socioeconomic assessment; and responsibility to cover the full costs for people who do not meet the eligibility requirements for support. Eligibility will be determined through a medical evaluation approved by the Ministry of Health or its affiliated institutions, which defines the individual's health status and specifies the type of prosthetic limb required. An evaluation conducted by the Ministry of Social Solidarity will also assess the beneficiary's economic and social conditions, determining whether they qualify for full, partial, or no financial support, she said. 'This system upholds social justice while preserving the dignity of citizens by ensuring access to prosthetic limbs that are appropriate to their medical and personal circumstances,' she stressed. The Ministry of Social Solidarity is currently developing a database to identify people with mobility impairments who require prosthetic limbs or devices using information from the Medical Commission and the Integrated Services System that classifies cases according to the type and severity of disability, as well as the actual level of need, Saroufim added. According to data released in July, there are 1.2 million people with mobility disabilities in Egypt, she said, calling on people with impairments to register in the Integrated Services System to determine their needs. * A version of this article appears in print in the 6 August, 2025 edition of Al-Ahram Weekly Follow us on: Facebook Instagram Whatsapp Short link:

13 Children Die of Hunger in Darfur IDP Camp
13 Children Die of Hunger in Darfur IDP Camp

See - Sada Elbalad

time4 days ago

  • See - Sada Elbalad

13 Children Die of Hunger in Darfur IDP Camp

By Ahmad El-Assasy The Sudanese Doctors Network has raised alarm over the deteriorating humanitarian conditions in the Lagawa Internally Displaced Persons (IDP) Camp in East Darfur, reporting the deaths of 13 children due to severe malnutrition in June alone. The camp, located in the city of El Daein, shelters over 7,000 displaced people, the majority of whom are women and children. According to a statement issued by the network, the camp is suffering from acute food shortages, which have led to a rapid increase in wasting and severe malnutrition, particularly among children. The statement added that in addition to hunger, camp residents are facing repeated attacks by armed groups, posing a serious threat to their safety and worsening the already dire humanitarian situation. The Sudanese Doctors Network called on the international community and humanitarian organizations to act immediately to deliver food, medical care, and protection to the displaced population. It specifically urged urgent aid for children and pregnant women, as well as the need to secure the camp from violence and ensure unhindered access for humanitarian aid. The situation in Lagawa Camp highlights the broader crisis unfolding across conflict-ridden regions of Sudan, where mass displacement, violence, and resource shortages continue to claim innocent lives. read more Gold prices rise, 21 Karat at EGP 3685 NATO's Role in Israeli-Palestinian Conflict US Expresses 'Strong Opposition' to New Turkish Military Operation in Syria Shoukry Meets Director-General of FAO Lavrov: confrontation bet. nuclear powers must be avoided News Iran Summons French Ambassador over Foreign Minister Remarks News Aboul Gheit Condemns Israeli Escalation in West Bank News Greek PM: Athens Plays Key Role in Improving Energy Security in Region News One Person Injured in Explosion at Ukrainian Embassy in Madrid News Israeli-Linked Hadassah Clinic in Moscow Treats Wounded Iranian IRGC Fighters Arts & Culture "Jurassic World Rebirth" Gets Streaming Date News China Launches Largest Ever Aircraft Carrier News Ayat Khaddoura's Final Video Captures Bombardment of Beit Lahia Videos & Features Tragedy Overshadows MC Alger Championship Celebration: One Fan Dead, 11 Injured After Stadium Fall Lifestyle Get to Know 2025 Eid Al Adha Prayer Times in Egypt Business Egyptian Pound Undervalued by 30%, Says Goldman Sachs Arts & Culture South Korean Actress Kang Seo-ha Dies at 31 after Cancer Battle Sports Get to Know 2025 WWE Evolution Results Arts & Culture Lebanese Media: Fayrouz Collapses after Death of Ziad Rahbani

Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion
Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion

Daily News Egypt

time5 days ago

  • Daily News Egypt

Minapharm Majority Shareholder Triquera Partners with Admaius Capital to Drive Global Biotech Expansion

Triquera B.V., the majority shareholder of Egyptian biopharmaceutical leader Minapharm, has secured a minority investment from Admaius Capital Partners in a landmark deal aimed at accelerating the regional and global expansion of Minapharm's biotechnology footprint. Admaius, an Africa-focused private equity firm, joins forces with Triquera to support the continued growth of Minapharm, which operates one of the largest biological drug substance and product facilities in the Middle East and Africa. The company is renowned for its end-to-end capabilities in manufacturing complex recombinant proteins, viral vectors, and advanced biologics, with operations in both Cairo and Berlin. The strategic partnership is expected to fast-track the development and distribution of affordable, high-quality genetically engineered therapies across underserved markets in Africa and the Middle East. It will also focus on expanding Minapharm's licensing of proprietary technologies in monoclonal antibodies, cell and gene therapies, and vaccines—many of which have been incorporated into FDA-approved products. The collaboration includes plans to explore strategic acquisitions of global contract development and manufacturing organizations (CDMOs), further positioning Minapharm as a competitive force in the global biotech industry. Strategic Alignment and Regional Impact Dr. Wafik Bardissi, Chairman and CEO of Minapharm, welcomed the partnership, stating: 'With Admaius, we gain not only capital but a strategic partner whose insight, alignment, and ambition match our own. Together, we are advancing regional self-sufficiency and expanding the global reach of our innovations.' Admaius Capital Partners Managing Partner Marlon Chigwende described the deal as a 'landmark transaction,' adding: 'The founding families have built a unique asset on the African and European continents that combines scale, growth, and impact to fight cancer and other awful diseases.' Ahmed Rady, Managing Director at Admaius, praised the Minapharm team's scientific and operational capabilities: 'This partnership is about scaling a homegrown champion that combines cutting-edge global know-how with end-to-end manufacturing excellence.' Dr. Shaheer Bardissi, Co-CEO of Minapharm, emphasized the broader industry implications of the deal: 'This strategic collaboration with Admaius will accelerate and scale Minapharm's vision of translating cutting-edge scientific innovation into affordable therapies, while advancing global scientific frontiers in immunotherapy and advanced therapy medicinal products.' Advisory Teams Zilla Capital acted as the sole financial advisor to Triquera and existing shareholders, while legal counsel was provided by Matouk Bassiouny. Admaius Capital Partners was advised by White & Case LLP and commercial consultant Arthur D. Little.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store